Investigational drug · Phase 3
CPL-01
Also called: local anaesthetic of CPL-01, Local anesthetic of CPL-01, Long-acting ropivacaine
Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Bunion, Postoperative Pain, Hernia, Inguinal.
Phase 3Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
3
1 still active
All registered trials
6
Any phase or sponsor naming "CPL-01"
First trial start
2023
Apr 18, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "CPL-01", any sponsor or status.
Conditions studied
As listed on its trial records.
- Bunion
- Postoperative Pain
- Hernia, Inguinal
- Post Operative Pain
- Post-operative Pain
Approved drugs for the same conditions: Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "CPL-01" as an intervention, largest first.
- CPL-01 in the Management of Postoperative Pain After BunionectomyPivotal-lookingCompleted
Cali Pharmaceuticals LLCIndustry
NCT05831449 · 616 participants · Start May 22, 2023 · Primary completion Sep 25, 2025
Drug: Local anesthetic injection of CPL-01; Naropin, 0.5% Injectable Solution and 4 more · For: Bunion; Post-operative Pain
Sites: Salt Lake City, Utah
- Herniorrhaphy for Postoperative PainPivotal-lookingCompleted
Cali Pharmaceuticals LLCIndustry
NCT05813847 · 518 participants · Start Apr 18, 2023 · Primary completion Sep 15, 2025
Drug: local anaesthetic injection of CPL-01; Morphine (rescue medication) and 4 more · For: Hernia, Inguinal; Post Operative Pain
Sites: Salt Lake City, Utah
- Phase 3 Bunionectomy StudyPivotal-lookingNot yet recruiting
Cali Pharmaceuticals LLCIndustry
NCT07490496 · 112 participants (planned) · Start Mar 1, 2027 · Primary completion Jun 30, 2027
Drug: CPL-01; saline placebo · For: Postoperative Pain; Bunion
Sites: Salt Lake City, Utah
- A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal HerniorrhaphyPivotal-lookingCompleted
Cali Pharmaceuticals LLCIndustry
NCT05080959 · 105 participants · Start Jul 28, 2021 · Primary completion Dec 31, 2021
Drug: CPL-01; Naropin 150 MG Per 20 ML Injection and 1 more · For: Inguinal Herniorrhaphy
Sites: Sheffield, Alabama; Phoenix, Arizona; Anaheim, California · 5 sites in all
Cali Pharmaceuticals LLCIndustry
NCT05411861 · 73 participants · Start Jun 14, 2022 · Primary completion Sep 26, 2022
Drug: Analgesic Non Narcotic · For: Hallux Valgus and Bunion
Sites: Phoenix, Arizona; Bakersfield, California; Salt Lake City, Utah
Cali Pharmaceuticals LLCIndustry
NCT04182880 · 20 participants · Start Jan 6, 2020 · Primary completion Feb 28, 2020
Drug: CPL-01; Placebo · For: Abdominoplasty
Sites: Pasadena, Maryland
Newest research
PubMed records naming it or its code names, newest first.
- Structural characterization and enhanced analgesic efficacy of a bio-responsive lyotropic liquid crystal Quject® gel for long-acting ropivacaine delivery.
Maharjan R, Lim DS, Baik HJ, et al. · Int J Pharm 2026
- Correction: Comparison of Pharmacokinetics of Long-Acting Local Analgesics: CPL-01, a Novel Extended-Release Ropivacaine, Demonstrates Consistent and Predictable Exposure Compared with Liposomal Bupivacaine.
Pope S, Crean C, Thrasher S, et al. · Clin Drug Investig 2025
- A carrier-free long-acting ropivacaine formulation using methylprednisolone sodium succinate as a dual-functional adjuvant.
Wu W, Wang Y, Qiu F, et al. · Theranostics 2025
- Efficacy, safety, and pharmacokinetics of CPL-01, an investigational long-acting ropivacaine, in bunionectomy: Results of a phase 2b study.
Xu HT, Zimmerman J, Bertoch T, et al. · J Foot Ankle Surg 2025
- Comparison of Pharmacokinetics of Long-Acting Local Analgesics: CPL-01, a Novel Extended-Release Ropivacaine, Demonstrates Consistent and Predictable Exposure Compared with Liposomal Bupivacaine.
Pope S, Crean C, Thrasher S, et al. · Clin Drug Investig 2025
- CPL-01, an investigational long-acting ropivacaine, demonstrates safety and efficacy in open inguinal hernia repair.
Xu HT, Zimmerman J, Bertoch T, et al. · Hernia 2024
Also in development for Bunion
- AMT-143Phase 21 trial
AmacaThera Inc. · Bunionectomy, Bunion
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.